Sentences with phrase «of translational research development»

«The opportunity for this career development is now,» says Graham Lord, director of translational research development at the National Institute for Health Research Biomedical Research Centre at King's College London and Guy's and St. Thomas» hospitals.

Not exact matches

The University of Tokyo conducts world - class interdisciplinary research, emphasizing translational applications and drug development with its new facilities.

Support for translational research has helped with the development of new drugs, diagnostics and vaccines, Hotez says, but funding for basic research has lagged behind.

An internationally - recognized scientist with more than 16 years of experience in translational immunoparasitology research and vaccine development for neglected tropical diseases, Bottazzi's major interest lies in the role of vaccines as control tools integrated into international public and global health programs and initiatives.

Translational Medicine: Bench Research & Baby Brain Development to Clinical Care Ruth Grunau, Ph.D., University of British Columbia

Today, Beckmann is president and executive director of Oregon Translational Research and Drug Development Institute (OTRADI), based at Portland State University.

«We are excited by the work of Dr. Pourdehnad and colleagues and believe these results are an important advance in understanding the role of myc pathway dysregulation in multiple myeloma, and ultimately allow for the development of therapeutic strategies to address it,» said Jeffrey Wolf, MD, a UCSF blood disorder specialist and director of the Stephen and Nancy Grand Multiple Myeloma Translational Initiative at UCSF, a sponsor of the research.

Looking ahead, cancer research looks set to thrive — particularly in the translational research arena and the development of new therapeutics.

The study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23 HD054720), Flora Family Foundation, UCSF Catalyst Award, UCSF Resource Allocation Program, Brain & Behavior Research Foundation Young Investigator Award, Stanford University Lucile Packard Foundation for Children's Health, Spectrum Child Health & Clinical and Translational Science Award and the Extraordinary Brain Series of the Dyslexia Foundation.

His research efforts are divided between preclinical models, the development, performance, and monitoring of cancer immunotherapy trials and the training of the next generation of translational investigators.

Reporting the results of a second study from the same group, Dr Suzanne Drury, a translational research and development scientist from Great Ormond Street Hospital, will describe the team's experience in the use of NIPD (non-invasive prenatal diagnosis) to diagnose the disorder congenital adrenal hyperplasia (CAH).

In their paper entitled, «Malaria in pregnancy alters L - arginine bioavailability and placental vascular development,» Science Translational Medicine, 7 March 2018, Toronto General Research Institute (TGRI) and University of Toronto researchers report that Malawian women with malaria in pregnancy had altered levels of L - arginine which were associated with poor birth outcomes.

By employing a translational approach and utilizing cutting - edge molecular tools, his research group has made outstanding contributions to our understanding of the mechanisms behind the development of chronic lymphocytic leukemia (CLL), the most common adult leukemia.

«Such evidence quantifying shared genetic risk factors among traditional psychiatric diagnoses will help us move toward classification that will be more faithful to nature,» said Bruce Cuthbert, Ph.D., director of the NIMH Division of Adult Translational Research and Treatment Development and coordinator of the Institute's Research Domain Criteria (RDoC) project, which is developing a mental disorders classification system for research based more on underlyingResearch and Treatment Development and coordinator of the Institute's Research Domain Criteria (RDoC) project, which is developing a mental disorders classification system for research based more on underlyingResearch Domain Criteria (RDoC) project, which is developing a mental disorders classification system for research based more on underlyingresearch based more on underlying causes.

The research was supported by the U.S. National Institute of Neurological Disorders and Stroke (NS101701, NS095279, NS095181), National Key Research and Development Program of China (Stem Cell and Translational Research), the National Natural Science Foundation of China, and Guangdong Presearch was supported by the U.S. National Institute of Neurological Disorders and Stroke (NS101701, NS095279, NS095181), National Key Research and Development Program of China (Stem Cell and Translational Research), the National Natural Science Foundation of China, and Guangdong PResearch and Development Program of China (Stem Cell and Translational Research), the National Natural Science Foundation of China, and Guangdong PResearch), the National Natural Science Foundation of China, and Guangdong Province.

All of the authors share a deep interest in clinical and translational research, and the editorial expresses a collective commitment to the development of an effective clinical and translational research work force.

Although Insel's blog was reported as a «bombshell,» and «potentially seismic,» NIMH's decision to scrap the DSM criteria has been public for several years, says Bruce Cuthbert, director of NIMH's Division of Adult Translational Research and Treatment Development.

The effort is the fruit of a new model of translational research being pursued at the Wyss Institute for Biologically Inspired Engineering at Harvard University that integrates the latest cancer research with bioinspired technology development.

M. D. Feldman, L. Huang, B. J. Guglielmo, R. Jordan, J. Kahn, J. M. Creasman, J. P. Wiener - Kronish, K. A. Lee, A. Tehrani, K. Yaffe, and J. S. Brown, «Training the next generation of research mentors: The University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program.»

«This study shows how translational research using basic science techniques in animal models can elucidate the underlying basis of human emotions and reasons for mental disorders, thereby pointing the way for treatment development,» says Jeffrey Lieberman, MD, Lawrence C. Kolb Professor and Chair of Psychiatry at CUIMC.

The basic premise of the work looks solid, says Juan Dominguez - Bendala, director of stem cell development for Translational Research at the University of Miami Miller School of Medicine's Diabetes Research Institute in Florida.

In this webinar, a panel of experts will discuss their research and describe the use of real - time, label - free cell monitoring in their investigation of novel cancer targets and the impact of their work on translational research and drug development.

The Center for Translational Injury Research (CeTIR) leads the research and development of next - generation medical technologies related to hemostasis, resuscitation and computerized decision support for trauma pResearch (CeTIR) leads the research and development of next - generation medical technologies related to hemostasis, resuscitation and computerized decision support for trauma presearch and development of next - generation medical technologies related to hemostasis, resuscitation and computerized decision support for trauma patients.

The research department has a significant number of translational research programmes involving the development of infectious disease vaccines, therapeutics and diagnostics.

Purpose: The development of the UNC Immuno - Oncology Patient Centered Translational Research (IMPACT) Biorepository involves the collection of tumor tissue and blood, as well as data (e.g., demographic, clinical, questionnaire) from patients attending Oncology Clinics at UNC Hospital and undergoing immune therapy through participation in a Merck IT trial at UNC.

EVI is a non-profit Product Development Partnership supporting the development of vaccines for diseases of poverty by bridging conceptual and operational gaps in translationaDevelopment Partnership supporting the development of vaccines for diseases of poverty by bridging conceptual and operational gaps in translationadevelopment of vaccines for diseases of poverty by bridging conceptual and operational gaps in translational research.

News and reports of the latest clinical trials, translational medicine, drug development and research with potential for direct impact on human health.

A major theme is translational research involving the rapid early - stage development and assessment of new vaccines in clinical trials.

The infrastructure consists of non-profit research institutes that engage in collaborative research and services in the translational phase of preventive, diagnostic and therapeutic product development.

Joining Mr. Solomon on the panel are leaders in neuroscience drug development, Richard Mohs, VP of Neuroscience Clinical Development at Eli Lilly, Rajesh Ranganathan, Director of the Office of Translational Research at NIH / NINDS, and Rudolph Tanzi, Vice-Chair of Neurology and Director of Genetics and Aging Research Unit at Harvard Medidevelopment, Richard Mohs, VP of Neuroscience Clinical Development at Eli Lilly, Rajesh Ranganathan, Director of the Office of Translational Research at NIH / NINDS, and Rudolph Tanzi, Vice-Chair of Neurology and Director of Genetics and Aging Research Unit at Harvard MediDevelopment at Eli Lilly, Rajesh Ranganathan, Director of the Office of Translational Research at NIH / NINDS, and Rudolph Tanzi, Vice-Chair of Neurology and Director of Genetics and Aging Research Unit at Harvard Medical School.

The meeting featured a keynote address from Bruce R. Conway, PhD, Director of the Robertson Therapeutic Development Fund at The Rockefeller University, as well as a panel discussion on best practices for translational science featuring Dr. Conway, Michael L. Batten, MD, MBA, of the JDRF T1D Fund, Andres Hurtado - Lorenzo, PhD, Director of Translational Research at the Crohn's & Colitis Foundation, Elizabeth Schwarzbach, PhD, Vice President of Business Development at NYSCF, and Caren A. Heller, MD, MBA, of the Crohn's & Colititranslational science featuring Dr. Conway, Michael L. Batten, MD, MBA, of the JDRF T1D Fund, Andres Hurtado - Lorenzo, PhD, Director of Translational Research at the Crohn's & Colitis Foundation, Elizabeth Schwarzbach, PhD, Vice President of Business Development at NYSCF, and Caren A. Heller, MD, MBA, of the Crohn's & ColitiTranslational Research at the Crohn's & Colitis Foundation, Elizabeth Schwarzbach, PhD, Vice President of Business Development at NYSCF, and Caren A. Heller, MD, MBA, of the Crohn's & Colitis Foundation.

Breast Cancer Research Foundation - AACR Career Development Award for Translational Breast Cancer Research Mary Kay Foundation Innovative Translational Grant Award Department of Defense Breast Research Program Breakthrough Award

Translational reproductive genetic research is aimed at basic as well as applied aspects of pre - and postimplanation development.

Dr. Zaks began his industry career at GlaxoSmithKline in the genetics research group, where he built the oncology translational medicine team and led translational research on lapatinib as well as the in - licensing and clinical development of foretinib.

I am also the director of the Center for the Study and Treatment of Fear and Anxiety and the PI / director of the Hispanic Clinical and Translational Research Education and Career Development Program.

Our group is specifically working on improvement of islet isolation and transplantation protocols in clinical practice and the development of novel therapeutic options in the field of beta cell replacement with a clear translational «bench to bedside» approach by linking experimental research with preclinical and clinical work:

This study and related investigations were supported by funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD082373), the National Institute of Neurological Disorders and Stroke (R24NS092989), the Atlanta Clinical & Translational Science Institute (UL1TR000454), and CURE Epilepsy: Citizens United for Research in Epilepsy.

Integral to Ronai's research are translational initiatives, including the development of SBI - 756, a small molecule that disrupts the complex that initiates protein synthesis and prevents melanoma resistance when combined with BRAF inhibition.

For this reason, the mission of the IFOM - IEO Campus is the development and application of genomics to research in basic and translational oncology.

Fellows will have a basic translational research mentor from CSHL as well as a clinical translational mentor from Northwell Health Cancer Institute to guide the development of their clinical research training throughout this fellowship program.

In addition, our basic science and translational research efforts — particularly in the areas of the gut microbiome, immunology, and microbiology — are contributing to the scientific advancement in the development, prevention, and treatment of IBD, and to the promise of more effective treatment strategies for future patients.

The mission of the Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM) is to improve human health by conducting basic and translational research that leads to the development of effective diagnostic biomarkers, vaccines, antivirals and therapeutics for emerging, re-emerging, neglected or rare infectious diseases.

The awards are intended to foster the development and productivity of mid-career physician - scientists who will strengthen translational research — the two - way transfer between basic research and the treatment of patients — through their own studies as well as their mentoring of the next generation of physician investigators.

«The CTR - IN is providing unique opportunities for junior faculty at our partner institutions to develop their clinical and translational research programs to the level of national competitiveness,» said Carl Reiber, UNLV senior vice provost, who was instrumental in the development of the program.

Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - ViralResearch, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viralresearch, Vaccine and Infectious Disease, Vaccine development - Viral cancers

Through a scientific peer - review process, the Research Program Committees (RPC) provide internal funding to promote the development of investigators initiating clinical or translational research pResearch Program Committees (RPC) provide internal funding to promote the development of investigators initiating clinical or translational research presearch projects.

Course on Translational Research and Medicine Development: The C - COMEND Course is a course consisting of an introductory e-learning (~ 24 hours student investment time) followed by a 5 - day face - to - face workshop.

She has also obtained a Breast Cancer Research Foundation American Association for Cancer Research (BCRF - AACR) Grant for Translational Breast Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, DiResearch Foundation American Association for Cancer Research (BCRF - AACR) Grant for Translational Breast Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, DiResearch (BCRF - AACR) Grant for Translational Breast Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, DiResearch to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Diresearch projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, DiResearch Excellence (SPORE; Carlos Arteaga, Director).

PRESENTERS: Philip Clifford, Ph.D., Associate Dean for Research at the College of Applied Health Sciences, Director of Mentoring for the UIC Center for Clinical and Translational Science, University of Illinois at Chicago; Brendan Delaney, J.D., Immigration Attorney, Frank & Delaney Immigration Law, LLC, Advisory Council member, NPA; Sina Safayi, D.V.M., Ph.D., Assistant Director of Career Development, Grad School, The University of Texas MD Anderson Cancer Center

The clinical biostatistics team has strong connection with the Biometry department (Head A. Savignoni), the early phase clinical trial and precision medicine unit where patients are treated with drugs in development (Head C. Le Tourneau), the translational research department in particular the Circulating Tumor Biomarkers laboratory (Charlotte Proudhon), and of course the other teams of the U900.